From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Developer(s) Axigen Messaging
Stable release
10.2.1 / May, 2018
Operating system Unix-like, Windows
Type Server
License Closed source / Demoware / Limited freeware

Axigen, marketed as AXIGEN, is a mail server with groupware and collaboration functionalities. It supports SMTP, IMAP, POP3 and webmail services, and includes features such as an integrated mailing list server, Antivirus and Antispam integration options, and various mobile capabilities including mobile-friendly webmail and Exchange ActiveSync support.

It is a Mailbox Provider-grade multi-tenant On-premises software. It can be hosted in data centers, on bare-metal or Private or Public Clouds of choice. It offers unsurpassed flexibility, scalability and security for email and groupware hosting that can be integrated into existing environments (for monitoring and alarming, centralized backup and restore, logging, provisioning and user database). At the same time, product teams can create competitive and highly differentiated Email hosting services for consumers, SMBs and SMEs. This elevates email hosting services to revenue generating and customer retention enabler levels


Development of Axigen Mail Server began in 2003 by GeCAD Technologies, a Romanian company established in 2001 and part of the GECAD Group. It was initially launched in September 2005.[1] In 2012 the Axigen product and technology was spun-off to new company Axigen Messaging, along with the original development team.[2][3] In January 2014, Axigen Messaging was sold to an investor group affiliated with Romanian I.T. services company Modulo Consulting.[4][5]


  1. ^ "Axigen Product Releases". Retrieved 26 April 2015.
  2. ^ "AXIGEN History". Retrieved 26 April 2015.
  3. ^ "Axigen Messaging | LinkedIn". Retrieved 26 April 2015.
  4. ^ "Gecad sells Axigen Messaging to group of entrepreneurs". Retrieved 27 April 2015.
  5. ^ "Romanian serial entrepreneur Radu Georgescu marks fourth exit with Axigen Messaging sale". Retrieved 27 April 2015.

External links[edit]